I hope you’re having some much needed time off for Thanksgiving, but for me — it’s business as usual.
Sure, the markets are closed today, but you know the saying, “Money never sleeps.”
I wanted to sneak away from the festivities today and take some time out to show you some catalyst plays to keep an eye on in the coming weeks.
If you know me, you know how I love to trade biotechs — and since these stocks are coming back into favor…
I think they’ll provide opportunities to play the catalyst runup.
3 Catalyst Runup Plays To Keep On The Radar
December is filled with catalyst events for biotech and pharmaceutical stocks. If you want to check out what companies are set to report data points, BioPharmCatalyst offers an extensive FDA calendar.
Since I know you want to get back to the festivities, I’m going to keep this brief.
Kiniksa Pharmaceuticals (KNSA) has a catalyst date in 4Q 2020, and since it hasn’t happened yet… it may come some time in December.
The company is expected to report data from randomized, double-blind, placebo-controlled investigator-initiated study in the U.S. for its COVID-19 treatment. By the looks of it, it may present this data at the Evercore ISI 3rd Annual HealthCONx on Tuesday.
The stock is already running higher, and it may continue its run into the event.
Odonate (ODT)has a catalyst date on Dec. 11.
The company met its Phase 3 trial primary endpoint back in August. Now, the company is expected to present data at SABCS, which will be held virtually. This data will be for its metastatic breast cancer treatment.
Last, but not least Myovant Sciences (MYOV)has a PDUFA date under priority review on Dec. 20.
With the stock running higher already, this is one to keep on the radar for a breakout.
Listen, anyone can provide you with trade ideas, it’s up to you to develop your own trade plan and have the right strategy in place.
Let me show you one of my best strategies… the same one that helped me get my trading career off the ground.